Business & Policy

Reishi™ & Ligne Roset Redefine Luxury in Interior Design

Last updated on 
Author: TEXTILE VALUE CHAIN

MycoWorks’ innovative biomaterial Reishi™ has entered a bold new chapter in interior design with its first industrial partnership with Ligne Roset, a leader in luxury furniture. Unveiled at the Palais de Tokyo during the Onirium event, the Kobold sofa by Erwan Bouroullec marks the debut of Reishi™ in a fully scaled commercial furniture product—bringing together aesthetic excellence, high performance, and sustainable innovation.

Reishi™, made using Fine Mycelium™ technology, is no longer just a concept. It now meets industrial-grade standards in strength, beauty, and durability—rivaling leather in elegance and endurance, but without animal-based components. Each piece of Reishi™ carries a unique organic texture, developing a patina over time, much like traditional luxury materials.

Why It Matters:

  • Durable & Resilient: Reishi™ withstands daily use, ideal for upholstery.
  • Naturally Distinct: Every piece is visually unique, mirroring organic textures like wood grain or marble.
  • Scalable & Sustainable: Unlike many biomaterials, Reishi™ is available in industrial volumes for global design brands.

Sophia Wang, co-founder of MycoWorks, emphasized, “This collaboration is proof that sustainable luxury is no longer a dream for tomorrow—it’s a tangible option today.”

Now part of the Ligne Roset 2025 collection, the Kobold sofa integrates modularity and eco-conscious materials, combining form, function, and ethics.

Antoine Roset, Managing Director at Ligne Roset, highlighted, “This partnership reflects our vision of combining innovation, Made in France quality, and environmental responsibility.”

Set in a lush green installation at the Onirium scenography, the Reishi™ Kobold sofa serves as an emblem of the evolving relationship between design and nature—ushering in a future where biomaterials elevate sustainable living without compromising on luxury or performance.

Subscribe to our Weekly E-Newsletter

Stay updated with the latest news, articles, and market reports, appointments, many more.

By subscribing you agree to our Terms and Privacy Policy.